DEPRESSION AND SUICIDALATTEMPTS AT TREATMENT ACNE VULGARIS WITH ISOTRETINOIN

L. Dejanović ,
L. Dejanović

Clinic for dermatological diseases KBC-Pristina , Kosovska Mitrovica , Kosovo*

M. Relić ,
M. Relić

Clinic for dermatological diseases Medical faculty Pristina , Kosovska Mitrovica , Kosovo*

T. Radević ,
T. Radević

Clinic for dermatological diseases Medical faculty Pristina , Kosovska Mitrovica , Kosovo*

M. Nenadović
M. Nenadović

Clinic for neuropsychiatric diseases Medical faculty Pristina , Kosovska Mitrovica , Kosovo*

Published: 01.01.2008.

Volume 36, Issue 1 (2008)

pp. 99-101;

https://doi.org/10.70949/pramed200801234D

Abstract

Oral isotretinoin is highly effective in treatment of patients with severe acne, but has been concerned with causing occasional depression. Clinicians should be alert to the high prevalence of depression among people with acne. Isotretinoin has many unwanted effects, among which possible unproven effects on mood have to be included. If depression or other mood change occurs, then isotretinoin treatment should be discontinued. If treatment is continued, psychiatric support should be obtained.

Keywords

References

1.
Simpson NB. Social and economic aspects of acne and the cost-effectiveness of isotretinoin. J Dermatol Treat. 4(suppl).
2.
Dermatologists. Isotretinoin BA. Advice on the safe introduction and continued use of isotretinoin in acne.
3.
Roaccutane. Summary of product characteristics.
4.
Cunliffe WJ. Roaccutane treatment guidelines: results of an international survey. Dermatology. 194:351–7.
5.
Hersom K. Isotretinoin and antidepressant pharmacotherapy: a prescription sequence symmetry analysis. J Am Acad Dermatol. 49:424–32.
6.
Wysowski DK, Beitz J. Methodological limitations of studies on isotretinoin use and depression, psychotic symptoms, suicide, and attempted suicide. Arch Dermatol. 137:1102–3.
7.
Cotteril J, Cunliffe WJ. Suicide in dermatological patients. Br J Dermatol. 137:246–50.
8.
Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis, and psoriasis. Br J Dermatol. 139:846–50.
9.
Lewinson PM. Major depressive disorder in older adolescents: prevalence, risk factors, and clinical implications. Clin Psychol Rev. 18:765–94.
10.
11.
Hong C, Schweitzer I. The association between depression and isotretinoin usage in acne. Aust N Z J Psych. 37:78–84.
12.
Isotretinoin. Summary of product characteristics UK. Schering Health Care Limited.
13.
Tsukada M. 13-cis retinoic acid exerts its specific activity on human sebocytes through selective intracellular isomerisation to all-trans retinoic acid and binding to retinoid acid receptors. J Invest Dermatol. 115:321–7.
14.
Cunliffe WJ, Baxter K. The place of oral isotretinoin in the treatment of acne: Benefits and side effects. CME Bulletin Dermatol. 2:56–62.
15.
Falton RH, Lee WL, Shalita AR. In vivo effect of isotretinoin on monocyte chemotaxis. J Invest Dermatol. 86:550–2.
16.
Leyden JJ, McGiffey KJ. Effect of 13-cis-retinoic acid on sebum production and Propionibacterium acnes in severe nodulocystic acne. Arch Dermatol Res. 272:331–7.
17.
Daiziel K, Barton S, Marks R. The effects of isotretinoin on follicular and sebaceous gland differentiation. Br J Dermatol. 117:317–23.
18.
King K, Jones DH, Daltrey DC. A double-blind study of the effects of 13-cis retinoic acid on acne, sebum excretion rate and microbial population. Br J Dermatol. 107:583–90.
19.
Pawin H, Beylot C, Chivot M, Fuare M, Poli F, Reuuz J, et al. Physiopathology of acne vulgaris: recent data, new understanding of treatments. Eur J Dermatol. 14:4–12.

Citation

Copyright

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Indexed by